Skip to main content
. 2021 Aug 2;23(10):2207–2214. doi: 10.1111/dom.14437

FIGURE 1.

FIGURE 1

Patient disposition. CKD, chronic kidney disease; CVD, cardiovascular disease; CVRD, cardiovascular and/or renal disease; DPP4i, dipeptidyl peptidase‐4 inhibitor; GD, gestational diabetes; HF, heart failure; MI, myocardial infarction; PAD, peripheral artery disease; Rx, prescribed; SGLT2i, sodium‐glucose co‐transporter‐2 inhibitor; TZD, thiazolidinedione; T1D, type 1 diabetes; T2D, type 2 diabetes